News in Brief

Glanbia and Lonza partner for capsule-in-capsule innovations

By Nikki Hancocks contact

- Last updated on GMT

Glanbia and Lonza partner for capsule-in-capsule innovations

Related tags: Innovation, partnership, capsules

Lonza and Glanbia Performance Nutrition have announced a collaboration which sees direct-to-consumer brand Body&Fit expand using Lonza’s DUOCAP technology and ingredients.

Glanbia's sports nutrition and dietary supplements brand Body&Fit​ is harnessing Lonza’s capsule-in-a-capsule technology to provide a unique delivery format enabling combined dosing of ingredients that may otherwise be incompatible.

The first two new products, Beauty Skin Duo and Pro B Duo, have already been launched. Both products use a titanium dioxide (TiO2​) -free inner capsule, catering to the clean label consumer trend.

Next, Body&Fit will launch three additional products for immune health and sleep, mood and anxiety in early 2021, all utilising the DUOCAP technology​.

Additionally, Body&Fit is developing a premium joint health and support supplement with the use of Lonza’s TiO2​-free ​hard capsules portfolio as well as its patented UC-II​ undenatured type II collagen ingredient, which is clinically proven to significantly improve mobility and joint comfort. This will make Body&Fit one of the first online direct-to-consumer brands to provide their consumers with this latest solution for joint health.

The collaboration will also see the exclusive development of an intra-workout product featuring Lonza’s new MuscleGuard​ formulation - a blend that delivers pre-, intra- and post-workout support.

Related news

Show more

Related products

show more

Turmacin®: Clean Label & Clinically Tested Turmeric

Turmacin®: Clean Label & Clinically Tested Turmeric

Natural Remedies Private Limited | 01-Sep-2021 | Product Presentation

Turmacin® is a clean label project-certified, clinically tested, and clinically safe turmeric extract. Turmacin® is rich in Turmerosaccharides® and doesn't...

How to Enter UK’s £690M CBD Market

How to Enter UK’s £690M CBD Market

The Association for the Cannabinoid Industry | 18-Jun-2021 | Technical / White Paper

The UK has the world’s most developed regulatory framework for legal cannabinoids, such as CBD and CBG. With a 2021 market estimated to be worth £690 million...

Related suppliers

Follow us


View more